JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.28% |
| 2 | Technology | 17.17% |
| 3 | Healthcare | 10.79% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
CNTA
4451
DELISTED
Centessa Pharmaceuticals
CNTA
| $382K | ﹤0.01% |
99,225
+86,478
| +678% | +$316K |
2021 Q2
7 quarters
|
|
4452
PUT
Helen of Troy
HELE
$590M
| $381K | ﹤0.01% |
+4,000
| New | +$428K |
2023 Q1
0 quarters
|
|
4453
MediciNova
MNOV
$81.2M
| $381K | ﹤0.01% |
176,376
-72,969
| -29% | -$167K |
2016 Q1
28 quarters
|
|
4454
VSE Corp
VSEC
$4.73B
| $380K | ﹤0.01% |
8,469
+2,066
| +32% | +$105K |
2013 Q2
39 quarters
|
|
4455
Matrix Service
MTRX
$304M
| $379K | ﹤0.01% |
70,260
-24,002
| -25% | -$167K |
2013 Q2
39 quarters
|
|
4456
Oramed Pharmaceuticals
ORMP
$182M
| $379K | ﹤0.01% |
174,122
-230,495
| -57% | -$732K |
2021 Q2
7 quarters
|
|
|
RENT
4457
Rent the Runway
RENT
$56M
| $379K | ﹤0.01% |
6,663
-1,485
| -18% | -$104K |
2021 Q4
5 quarters
|
|
|
VLRS
4458
Controladora Vuela Compania de Aviacion
VLRS
$747M
| $379K | ﹤0.01% |
+30,427
| New | +$337K |
2023 Q1
0 quarters
|
|
|
DBTX
4459
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
| $379K | ﹤0.01% |
125,661
-4,911
| -4% | -$17K |
2021 Q1
8 quarters
|
|
4460
TFS Financial
TFSL
$4.65B
| $378K | ﹤0.01% |
29,965
+4,305
| +17% | +$60.1K |
2017 Q4
21 quarters
|
|
4461
State Street SPDR Bloomberg International Treasury Bond ETF
BWX
$1.3B
| $377K | ﹤0.01% |
16,327
+3,479
| +27% | +$79.4K |
2013 Q2
39 quarters
|
|
4462
Paysafe
PSFE
$290M
| $377K | ﹤0.01% |
21,815
+5,310
| +32% | +$103K |
2021 Q1
8 quarters
|
|
|
REVG
4463
DELISTED
REV Group
REVG
| $377K | ﹤0.01% |
31,378
+910
| +3% | +$11.3K |
2017 Q3
22 quarters
|
|
|
AEVA
4464
Aeva Technologies
AEVA
$1.02B
| $376K | ﹤0.01% |
63,201
-217
| -0.3% | -$1.74K |
2021 Q2
7 quarters
|
|
4465
BlackRock MuniYield Quality Fund III
MYI
$1.18B
| $376K | ﹤0.01% |
+33,125
| New | +$370K |
2023 Q1
0 quarters
|
|
|
TVRD
4466
Tvardi Therapeutics
TVRD
$14.4M
| $375K | ﹤0.01% |
2,116
+202
| +11% | +$67.6K |
2014 Q1
36 quarters
|
|
4467
Esquire Financial Holdings
ESQ
$1.41B
| $374K | ﹤0.01% |
9,560
+2,138
| +29% | +$90.1K |
2018 Q2
19 quarters
|
|
|
ALPN
4468
DELISTED
Alpine Immune Sciences Inc
ALPN
| $372K | ﹤0.01% |
48,149
+33,919
| +238% | +$270K |
2021 Q2
7 quarters
|
|
|
ZIMV
4469
DELISTED
ZimVie
ZIMV
| $370K | ﹤0.01% |
51,360
+31,458
| +158% | +$268K |
2022 Q1
4 quarters
|
|
4470
CALL
MBIA
MBI
$227M
| $370K | ﹤0.01% |
40,000
| – | – |
2022 Q4
1 quarter
|
|
4471
Oil-Dri
ODC
$1.28B
| $369K | ﹤0.01% |
17,742
+17,686
| +31,582% | +$327K |
2022 Q4
1 quarter
|
|
4472
BlackRock MuniYield Michigan Quality Fund
MIY
$324M
| $369K | ﹤0.01% |
32,996
-693
| -2% | -$7.91K |
2022 Q4
1 quarter
|
|
4473
Universal Insurance Holdings
UVE
$1.21B
| $369K | ﹤0.01% |
20,219
-4,085
| -17% | -$60.4K |
2015 Q1
32 quarters
|
|
|
AGEN
4474
Agenus
AGEN
$338M
| $368K | ﹤0.01% |
12,343
+3,073
| +33% | +$130K |
2017 Q3
22 quarters
|
|
4475
Direxion Daily AMZN Bull 2X ETF
AMZU
$360M
| $368K | ﹤0.01% |
21,647
-3,353
| -13% | -$52.5K |
2022 Q3
2 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.